Global CTLA4 Inhibitors Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	204 Pages	TechNavio	February, 2025	INF19750093

Best Price Guarantee
Price	from $2,500
Length	204 Pages
Publisher	TechNavio
Published Date	February, 2025
SKU	INF19750093

CTLA4 Inhibitors Market 2025-2029

The CTLA4 inhibitors market is forecasted to grow by USD 3500.2 million during 2024-2029, accelerating at a CAGR of 19.1% during the forecast period. The report on the CTLA4 inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high target affinity and specificity of CTLA4 inhibitors, growing popularity of combination therapy, and strategic alliances in developing CTLA4 inhibitors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's CTLA4 inhibitors market is segmented as below:

By Type

Monotherapy
Combination therapy

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Route Of Administration

Intravenous
Subcutaneous

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the expansion of research indications of CTLA4 as one of the prime reasons driving the CTLA4 inhibitors market growth during the next few years. Also, special drug designations of CTLA4 inhibitors and increasing awareness about cancer will lead to sizable demand in the market.

The report on the CTLA4 inhibitors market covers the following areas:

CTLA4 Inhibitors Market sizing
CTLA4 Inhibitors Market forecast
CTLA4 Inhibitors Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ctla4 inhibitors market vendors that include Agenus Inc., Akeso Inc., AstraZeneca PLC, Bio Techne Corp., BioNTech SE, Bristol Myers Squibb Co., HBM Holdings Ltd., Innovent Biologics Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., and Xencor Inc.. Also, the CTLA4 inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global CTLA4 Inhibitors Market 2019 - 2023; Historic Market Size - Data Table on Global CTLA4 Inhibitors Market 2019 - 2023 ($ million); 5.2 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.3 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); 5.4 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on Global CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type: 8.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 8.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 8.3 Monotherapy - Market size and forecast 2024-2029; Chart on Monotherapy - Market size and forecast 2024-2029 ($ million); Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million); Chart on Monotherapy - Year-over-year growth 2024-2029 (%); Data Table on Monotherapy - Year-over-year growth 2024-2029 (%); 8.4 Combination therapy - Market size and forecast 2024-2029; Chart on Combination therapy - Market size and forecast 2024-2029 ($ million); Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million); Chart on Combination therapy - Year-over-year growth 2024-2029 (%); Data Table on Combination therapy - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Distribution Channel: 9.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 9.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 9.3 Hospital pharmacies - Market size and forecast 2024-2029; Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%); 9.4 Retail pharmacies - Market size and forecast 2024-2029; Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%); 9.5 Online pharmacies - Market size and forecast 2024-2029; Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Online pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%); 9.6 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration: 10.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 10.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 10.3 Intravenous - Market size and forecast 2024-2029; Chart on Intravenous - Market size and forecast 2024-2029 ($ million); Data Table on Intravenous - Market size and forecast 2024-2029 ($ million); Chart on Intravenous - Year-over-year growth 2024-2029 (%); Data Table on Intravenous - Year-over-year growth 2024-2029 (%); 10.4 Subcutaneous - Market size and forecast 2024-2029; Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million); Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million); Chart on Subcutaneous - Year-over-year growth 2024-2029 (%); Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%); 10.5 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.9 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.10 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.11 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.12 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.13 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.14 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.15 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 12.16 The Netherlands - Market size and forecast 2024-2029; Chart on The Netherlands - Market size and forecast 2024-2029 ($ million); Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million); Chart on The Netherlands - Year-over-year growth 2024-2029 (%); Data Table on The Netherlands - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 Agenus Inc.; Agenus Inc. - Overview; Agenus Inc. - Product / Service; Agenus Inc. - Key offerings; SWOT; 15.5 Akeso Inc.; Akeso Inc. - Overview; Akeso Inc. - Product / Service; Akeso Inc. - Key offerings; SWOT; 15.6 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 15.7 Bio Techne Corp.; Bio Techne Corp. - Overview; Bio Techne Corp. - Business segments; Bio Techne Corp. - Key news; Bio Techne Corp. - Key offerings; Bio Techne Corp. - Segment focus; SWOT; 15.8 BioNTech SE; BioNTech SE - Overview; BioNTech SE - Product / Service; BioNTech SE - Key offerings; SWOT; 15.9 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 15.10 HBM Holdings Ltd.; HBM Holdings Ltd. - Overview; HBM Holdings Ltd. - Product / Service; HBM Holdings Ltd. - Key offerings; SWOT; 15.11 Innovent Biologics Inc.; Innovent Biologics Inc. - Overview; Innovent Biologics Inc. - Product / Service; Innovent Biologics Inc. - Key offerings; SWOT; 15.12 Jiangsu Hengrui Pharmaceuticals Co. Ltd.; Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview; Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service; Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings; SWOT; 15.13 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 15.14 Ono Pharmaceutical Co. Ltd.; Ono Pharmaceutical Co. Ltd. - Overview; Ono Pharmaceutical Co. Ltd. - Product / Service; Ono Pharmaceutical Co. Ltd. - Key offerings; SWOT; 15.15 Shanghai Fosun Pharmaceutical Group Co. Ltd.; Shanghai Fosun Pharmaceutical Group Co. Ltd. - Overview; Shanghai Fosun Pharmaceutical Group Co. Ltd. - Business segments; Shanghai Fosun Pharmaceutical Group Co. Ltd. - Key offerings; Shanghai Fosun Pharmaceutical Group Co. Ltd. - Segment focus; SWOT; 15.16 Xencor Inc.; Xencor Inc. - Overview; Xencor Inc. - Product / Service; Xencor Inc. - Key offerings; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global CTLA4 Inhibitors Market 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Type - Market share 2024-2029 (%); Exhibits39: Data Table on Type - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Type; Exhibits41: Data Table on Comparison by Type; Exhibits42: Chart on Monotherapy - Market size and forecast 2024-2029 ($ million); Exhibits43: Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million); Exhibits44: Chart on Monotherapy - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on Monotherapy - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Combination therapy - Market size and forecast 2024-2029 ($ million); Exhibits47: Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million); Exhibits48: Chart on Combination therapy - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Combination therapy - Year-over-year growth 2024-2029 (%); Exhibits50: Market opportunity by Type ($ million); Exhibits51: Data Table on Market opportunity by Type ($ million); Exhibits52: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits53: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits54: Chart on Comparison by Distribution Channel; Exhibits55: Data Table on Comparison by Distribution Channel; Exhibits56: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits57: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits58: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%); Exhibits59: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%); Exhibits60: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits61: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits62: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%); Exhibits63: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%); Exhibits64: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits65: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits66: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%); Exhibits67: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%); Exhibits68: Market opportunity by Distribution Channel ($ million); Exhibits69: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits70: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits71: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits72: Chart on Comparison by Route of Administration; Exhibits73: Data Table on Comparison by Route of Administration; Exhibits74: Chart on Intravenous - Market size and forecast 2024-2029 ($ million); Exhibits75: Data Table on Intravenous - Market size and forecast 2024-2029 ($ million); Exhibits76: Chart on Intravenous - Year-over-year growth 2024-2029 (%); Exhibits77: Data Table on Intravenous - Year-over-year growth 2024-2029 (%); Exhibits78: Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million); Exhibits79: Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million); Exhibits80: Chart on Subcutaneous - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%); Exhibits82: Market opportunity by Route of Administration ($ million); Exhibits83: Data Table on Market opportunity by Route of Administration ($ million); Exhibits84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits85: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits86: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits87: Chart on Geographic comparison; Exhibits88: Data Table on Geographic comparison; Exhibits89: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits90: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits91: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits93: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits94: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits95: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Italy - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on Italy - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on Italy - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Italy - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on India - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on India - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on The Netherlands - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%); Exhibits145: Market opportunity By Geographical Landscape ($ million); Exhibits146: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits147: Impact of drivers and challenges in 2024 and 2029; Exhibits148: Overview on criticality of inputs and factors of differentiation; Exhibits149: Overview on factors of disruption; Exhibits150: Impact of key risks on business; Exhibits151: Companies covered; Exhibits152: Company ranking index; Exhibits153: Matrix on companies position and classification; Exhibits154: Agenus Inc. - Overview; Exhibits155: Agenus Inc. - Product / Service; Exhibits156: Agenus Inc. - Key offerings; Exhibits157: SWOT; Exhibits158: Akeso Inc. - Overview; Exhibits159: Akeso Inc. - Product / Service; Exhibits160: Akeso Inc. - Key offerings; Exhibits161: SWOT; Exhibits162: AstraZeneca Plc - Overview; Exhibits163: AstraZeneca Plc - Product / Service; Exhibits164: AstraZeneca Plc - Key news; Exhibits165: AstraZeneca Plc - Key offerings; Exhibits166: SWOT; Exhibits167: Bio Techne Corp. - Overview; Exhibits168: Bio Techne Corp. - Business segments; Exhibits169: Bio Techne Corp. - Key news; Exhibits170: Bio Techne Corp. - Key offerings; Exhibits171: Bio Techne Corp. - Segment focus; Exhibits172: SWOT; Exhibits173: BioNTech SE - Overview; Exhibits174: BioNTech SE - Product / Service; Exhibits175: BioNTech SE - Key offerings; Exhibits176: SWOT; Exhibits177: Bristol Myers Squibb Co. - Overview; Exhibits178: Bristol Myers Squibb Co. - Product / Service; Exhibits179: Bristol Myers Squibb Co. - Key news; Exhibits180: Bristol Myers Squibb Co. - Key offerings; Exhibits181: SWOT; Exhibits182: HBM Holdings Ltd. - Overview; Exhibits183: HBM Holdings Ltd. - Product / Service; Exhibits184: HBM Holdings Ltd. - Key offerings; Exhibits185: SWOT; Exhibits186: Innovent Biologics Inc. - Overview; Exhibits187: Innovent Biologics Inc. - Product / Service; Exhibits188: Innovent Biologics Inc. - Key offerings; Exhibits189: SWOT; Exhibits190: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview; Exhibits191: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service; Exhibits192: Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings; Exhibits193: SWOT; Exhibits194: Merck and Co. Inc. - Overview; Exhibits195: Merck and Co. Inc. - Business segments; Exhibits196: Merck and Co. Inc. - Key news